blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1311668

EP1311668 - COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  16.04.2010
Database last updated on 24.08.2024
Most recent event   Tooltip16.04.2010Withdrawal of applicationpublished on 19.05.2010  [2010/20]
Applicant(s)For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
[N/P]
Former [2008/38]For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco CA 94080-4990 / US
Former [2003/21]For all designated states
GENENTECH, INC.
1 DNA Way
South San Francisco California 94080 / US
Inventor(s)01 / ASHKENAZI, Avi, J.
1456 Tarrytown Street
San Mateo, CA 94402 / US
02 / GODDARD, Audrey
110 Congo Street
San Francisco, CA 94131 / US
03 / GODOWSKI, Paul, J.
2627 Easton Drive
Burlingame, CA 94010 / US
04 / GURNEY, Austin, L.
1 Debbie Lane
Belmont, CA 94002 / US
05 / POLAKIS, Paul
1449 Cortez Avenue
Burlingame, CA 94010 / US
06 / WILLIAMS, P., Mickey
509 Alto Avenue
Half Moon Bay, CA 94019 / US
07 / WOOD, William, I.
35 Southdown Court
Hillsborough, CA 94010 / US
08 / WU, Thomas, D.
113 Elsie Street
San Francisco, CA 94110 / US
09 / ZHANG, Zemin
876 Taurus Drive
Foster City, CA 94404 / US
 [2003/21]
Representative(s)Denison, Christopher Marcus, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2003/21]Denison, Christopher Marcus, et al
Mewburn Ellis York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date01966255.023.08.2001
[2003/21]
WO2001US26626
Priority number, dateWO2000US2332824.08.2000         Original published format: PCT/US00/23328
WO2000US3267801.12.2000         Original published format: PCT/US00/32678
WO2001US0652028.02.2001         Original published format: PCT/US01/06520
WO2001US1780001.06.2001         Original published format: PCT/US01/17800
WO2001US1969220.06.2001         Original published format: PCT/US01/19692
WO2001US2106629.06.2001         Original published format: PCT/US01/21066
WO2001US2173509.07.2001         Original published format: PCT/US01/21735
[2003/21]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0216602
Date:28.02.2002
Language:EN
[2002/09]
Type: A2 Application without search report 
No.:EP1311668
Date:21.05.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 28.02.2002 takes the place of the publication of the European patent application.
[2003/21]
Search report(s)International search report - published on:EP06.02.2003
ClassificationIPC:C12N15/00, C07K16/30, A61K47/48
[2003/21]
CPC:
A61K38/20 (EP); A61P1/04 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P15/00 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P43/00 (EP);
C07K14/54 (EP); C07K14/7155 (EP); C12N15/1136 (EP);
C12N2310/11 (EP); C12N2310/12 (EP); C12N2310/15 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/21]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ZUSAMMENENSETZUNGEN UND VERFAHREN FÜR DIAGNOSE UND BEHANDLUNG EINES TUMORS[2003/21]
English:COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR[2003/21]
French:COMPOSITIONS ET PROCEDES CON US POUR LE DIAGNOSTIC ET LE TRAITEMENT DE TUMEUR[2003/21]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase13.03.2003National basic fee paid 
13.03.2003Designation fee(s) paid 
13.03.2003Examination fee paid 
Examination procedure05.03.2002Request for preliminary examination filed
International Preliminary Examining Authority: US
13.03.2003Examination requested  [2003/21]
24.11.2006Despatch of a communication from the examining division (Time limit: M06)
29.05.2007Reply to a communication from the examining division
30.07.2007Despatch of a communication from the examining division (Time limit: M06)
27.03.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
03.06.2008Reply to a communication from the examining division
20.02.2009Despatch of a communication from the examining division (Time limit: M04)
02.07.2009Reply to a communication from the examining division
09.04.2010Application withdrawn by applicant  [2010/20]
09.04.2010Cancellation of oral proceeding that was planned for 30.09.2010
30.09.2010Date of oral proceedings (cancelled)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
02.06.2008Request for further processing filed
Fees paidRenewal fee
13.08.2003Renewal fee patent year 03
12.08.2004Renewal fee patent year 04
12.08.2005Renewal fee patent year 05
14.08.2006Renewal fee patent year 06
14.08.2007Renewal fee patent year 07
14.08.2008Renewal fee patent year 08
12.08.2009Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO0012708  (GENENTECH, INC.) [X] 1-5 * claims 12,17-20 * * figure 246 *;
 [X]WO9946281  (GENENTECH, INC.) [X] 1-5 * claims 12,17,18 * * figures 87,190 * * seq.id.nos 236 and 459 *;
 [X]WO9940189  (GENSET) [X] 1-5 * claims 6-12,17,20 * * seq.id.no. 123 *;
 [X]WO0023108  (DIADEXUS LLC) [X] 1-5,8,15 * claim - * * seq.id.no.2 *;
 [A]EP0388914  (BEHRINGWERKE AG) [A] 1-15 * the whole document *;
 [A]  - R. CHARI ET AL., "Immunoconjugates containing novel maytansinoids: promising anticancer drugs.", CANCER RESEARCH, Baltimore, MD, USA, (19920101), vol. 52, no. 1, pages 127 - 131, XP000453560 [A] 1-15 * abstract *
Examination   - MOLECULAR AND CELLULAR PROTEOMICS, (2002), vol. 1, pages 37 - 45
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.